Effects of ABL SH3-T79Y mutant combined with imatinib on the proliferation of chronic myeloid leukemia cells
Liang-xue Wen(Chongqing Medical University), Wenli Feng(Children's Hospital of Chongqing Medical University), Ningshu Huang(China International Science and Technology Cooperation), Xin Liu(The University of Texas MD Anderson Cancer Center), Hui Li(Shanghai Stomatological Hospital), Zhenglan Huang(Chongqing Medical University)
DOAJ (DOAJ: Directory of Open Access Journals)
January 8, 2015
Cited by 0
Related Papers
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma
|Molecular Cancer Research|2015|235
Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
|Cell stem cell|2019|179
Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis
|Journal of Autoimmunity|2019|173
IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis
|Cell Death and Disease|2017|137